Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Disease × Bupivacaine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 24 Breast Neoplasms 20 Agnosia 9 Pain 8 Lung Neoplasms 8 Leiomyoma 6 Pancreatic Neoplasms 5 Neoplasms 5 Rectal Neoplasms 3 Prostatic Neoplasms 3 Neuralgia 3 Hot Flashes 3 Colorectal Neoplasms 3 Thyroid Nodule 2 Thyroid Neoplasms 2 Neuroma 2 Kidney Neoplasms 2 Ileus 2 Hyperparathyroidism 2 Goiter 2 Digestive System Diseases 2 Colonic Neoplasms 2 Chronic Pain 2 Breast Cancer Female 2 Brain Neoplasms 2 Abdominal Cancer 2 post laminectomy syndrome 1 Vesico-Ureteral Reflux 1 Uterine Neoplasms 1 Uterine Cervical Dysplasia 1

Interventions

Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Blood Specimen Collection 6 Cyclophosphamide 5 Prednisone 4 Positron Emission Tomography Computed Tomography 4 Mammography 4 Lenalidomide 4 Colonoscopy 4 Tomography, X-Ray Computed 3 Surveys and Questionnaires 3 Melphalan 3 Biopsy 3 weifuchun 2 pembrolizumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Magnetic Resonance Imaging 2 Injections 2 Gemcitabine 2 Cytarabine 2 Control Groups 2 Biopsy, Fine-Needle 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 vistusertib 1 venetoclax 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07254650 2025-11-28

CALMS-1

University of Texas Southwestern Medical Center

Phase NA Not yet recruiting

Agnosia, Disease, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡